Changes in Human Immunodeficiency Virus Type 1 Populations after Treatment Interruption in Patients Failing Antiretroviral Therapy

Mutations in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and protease that confer resistance to antiretroviral agents are usually accompanied by a reduction in the viral replicative capacity under drug-free conditions. Consequently, when antiretroviral treatment is interrupted...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Hance, Allan J., Lemiale, Virginie, Izopet, Jacques, Lecossier, Denise, Joly, Véronique, Massip, Patrice, Mammano, Fabrizio, Descamps, Diane, Brun-Vézinet, Françoise, Clavel, François
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC114364/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11413308/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.14.6410-6417.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!